Lilly to Provide Detailed Review of Elanco Animal Health and Alzheimer's R&D Strategy at Investment Community Meeting
The meeting will take place
In the meeting, company leaders will provide an overview of
"We look forward to providing details on two key areas of focus for our company, animal health and Alzheimer's disease," said
A live webcast of the Lilly investment community meeting, along with presentation slides, will be available through a link on the investor section of Lilly's website at https://investor.lilly.com/. The webcast will be available for replay over the next 12 months.
Media interested in attending in person should contact
About
Lilly is a global healthcare leader that unites caring with discovery to make life better for people around the world. We were founded more than a century ago by a man committed to creating high-quality medicines that meet real needs, and today we remain true to that mission in all our work. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism. To learn more about Lilly, please visit us at www.lilly.com and newsroom.lilly.com/social-channels. (C-LLY)
Refer to: Lauren Zierke; lauren_zierke@lilly.com; 317-277-6524 (Media)
Logo - http://photos.prnewswire.com/prnh/20031219/LLYLOGO
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/lilly-to-provide-detailed-review-of-elanco-animal-health-and-alzheimers-rd-strategy-at-investment-community-meeting-300182521.html
SOURCE
News Provided by Acquire Media